374145080 | cmc | 37710772 | | 7613746 | 2/22/2007 12:00:00 am | chf; hemoptysis | | dis | admission date: 11/16/2007 report status:discharge date: 9/3/2007 final discharge orders crummey , jr , oscar 528-81-05-2ni blvd. , co , montana 90711service: cardischarge patient on: 8/29/07 at 01:00 pmcontingent upon ho evaluationwill d/c order be used as the d/c summary: yesattending: lanagan , irwin angelo , m.d.code status:full codedisposition: homemedications on admission:1. acetylsalicylic acid 325 mg po qd2. alendronate 70 mg po qweek3. atorvastatin 40 mg po qd4. calcium carbonate ( 500 mg elemental ca++ ) 1250 mg po tid5. clopidogrel 75 mg po qd6. cyclosporine micro ( neoral ) 50 mg po bid7. diltiazem cd ( 24 hr caps ) 300 mg po qd8. doxazosin 4 mg po qd9. hydrochlorothiazide 12.5 mg po qd10. magnesium oxide ( 241 mg elemental mg ) 400 mg po qd11. niferex 150 150 mg po bid12. prednisone 5 mg po qam13. sirolimus 2 mg po qd14. esomeprazole 20 mg po qd15. metoprolol succinate extended release 25 mg po qdmedications on discharge:acetylsalicylic acid 325 mg po dailyalert overridden: override added on 1/12/07 byromie , joaquin o. , m.d.on order for acetylsalicylic acid po ( ref # 149904062 )pt. has a definite allergy to aspirin; reaction is orbitaledema. reason for override:patient has had desensitization ,and needs aspirin given stent. home med.fosamax ( alendronate ) 70 mg po qweekfood/drug interaction instructiongive on an empty stomach ( give 1hr before or 2hr afterfood ) take with 8 oz of plain wateralert overridden: override added on 8/29/07 by :potentially serious interaction: cyclosporine &alendronate sodium reason for override: awarelipitor ( atorvastatin ) 40 mg po dailyalert overridden: override added on 8/29/07 by :potentially serious interaction: cyclosporine &atorvastatin calcium reason for override: awarecalcium carbonate ( 500 mg elemental ca++ ) 500 mg po tidplavix ( clopidogrel ) 75 mg po dailyneoral cyclosporine ( cyclosporine micro ( neoral ) )100 mg po bid food/drug interaction instructionavoid grapefruit unless md instructs otherwise.give with mealsoverride notice: override added on 5/16/07 by annabel , lesley ronny , m.d.on order for simvastatin po 40 mg qhs ( ref # 620856181 )potentially serious interaction: cyclosporine & simvastatinreason for override: mda previous override information:override added on 8/8/07 by :potentially serious interaction: simvastatin & cyclosporinereason for override: mda previous override noticeoverride added on 8/8/07 by bugbee , cruz e. , m.d.on order for simvastatin po ( ref # 430842588 )potentially serious interaction: cyclosporine & simvastatinreason for override: aware previous override information:override added on 1/12/07 by rafalski , delbert k. , m.d.potentially serious interaction: atorvastatin calcium &cyclosporine reason for override: aware. home med.diltiazem cd ( 24 hr caps ) 300 mg po dailyfood/drug interaction instructionavoid grapefruit unless md instructs otherwise.alert overridden: override added on 8/29/07 by :potentially serious interaction: metoprolol tartrate &diltiazem hcl reason for override: aware. home meds.cardura ( doxazosin ) 4 mg po daily hold if: \nexium ( esomeprazole ) 20 mg po dailylasix ( furosemide ) 40 mg po dailystarting in am ( 1/9 )potassium chloride slow rel. ( kcl slow release )10 meq po daily as per oh potassium chloride policy:each 20 meq dose to be given with 4 oz of fluidlevofloxacin 500 mg po every other day x 8 daysstarting today ( 5/3 ) instructions: last day 6/2/07food/drug interaction instructionadminister iron products a minimum of 2 hours before orafter a levofloxacin or ciprofloxacin dose doseif on tube feeds , please cycle ( hold 1 hr before to 2 hrafter ) take 2 hours before or 2 hours after dairy products.alert overridden: override added on 8/8/07 bywendt , salvatore , m.d. , ph.d.potentially serious interaction: polysaccharide ironcomplex & levofloxacin reason for override: mdamagnesium oxide ( 241 mg elemental mg ) 400 mg po dailytoprol xl ( metoprolol succinate extended release )25 mg po daily food/drug interaction instructiontake consistently with meals or on empty stomach.alert overridden: override added on 8/29/07 by :potentially serious interaction: diltiazem hcl &metoprolol tartratepotentially serious interaction: diltiazem hcl &metoprolol tartrate reason for override: aware. home med.niferex 150 150 mg po bidoverride notice: override added on 8/8/07 bycraighead , sheldon , m.d. , ph.d.on order for levofloxacin po ( ref # 393016310 )potentially serious interaction: polysaccharide ironcomplex & levofloxacin reason for override: mdaprednisone 5 mg po qamdiet: patient should measure weight dailydiet: fluid restrictiondiet: house / low chol/low sat. fatdiet: 2 gram sodiumactivity: please use oxygenfollow up appointment( s ):your pcp dr. lugones - please call for an appointment in one week ,cardiac transplant , rh dera ph 051-469-9935 1/12/07 at 11:15am scheduled ,dr. hirose , pulmonary , rsch ponce , utah 01302 ph 234-865-1925 9/9/07 at 1pm scheduled ,pet ct scan - before your pulmonary appt - please go to greencam lu ge at sgogrove faysonco , nuclear medicine 9/9/07 at 10:40am scheduled ,allergy: aspirin , procainamide hcl , ace inhibitoradmit diagnosis:shortness of breathprincipal discharge diagnosis ;responsible after study for causing admission )chf; hemoptysisother diagnosis;conditions , infections , complications , affecting treatment/stayheart transplant 1997 ( cad , ischemic cardiomyopathy ); allograftvasculopathy - mi sp pci to lad in 10/24 ); h/o pulmonary hemorrhage andhemoptysis 11/12 lung mass v atelectatic lung on ct; claudication;niddm; htn; nasal polypsoperations and procedures:bronchoscopy 11/8/07 : active bleeding from rml bronchus , which preventedvisualization of the subsegments or assessment of the bronchus. bal ofthe rml orifice could not be achieved.other treatments/procedures ( not in o.r. )adjustment of immune suppressants , addition of diuretics , empiriclevofloxacin.lenis negative.brief resume of hospital course:cc: sobhpi: 58yo m with h/o ischemic cardiomyopathy s/p heart transplant 1997c/b allograft vasculopathy , cad s/p lad stent 10/24 , asa desensitization ,recent admission for pulmonary hemorrhage/pna presents withhemoptysis. over past week , developed st , cough , increasingorthopnea , pnd , wheezing and worsening doe. no chest pain , leg pain.no f/c , no epistaxis. seen in clinic today , found to have o2 sat 89%and rle swelling , sent to ed. in ed , afeb , p95 , 165/82 , 90%on ra ( baseline 92-93% ). pe-ct negative for pe. given ivfs but thendiuresed.pmh: cabg 1990 , icmp s/p transplant 1997 c/b allograph vasculopathy( biopsy 11/29 neg for rejection ) , s/p lad stent 10/24 , claudication ,diet controlled dm , htn , nasal polyps.all: procainamide , asa ( desensitized )admission exam: afeb , p90 , 142/70 , 28 , 92-93% on2l tachypneic , decreased bs at bases , jvp 10 , rrr nom/g/r , prominent pmi , abd bengin , lle 2+ edema , rle no edema , 2+ dpbilat , warm extstudies creat 1.7 ( baseline ) , hct 31( stable ) abg on ra 7.45/34/63ekg 7/10 nsr , 1st degree avb , nonspecific st-t , no change from priorpe-ct 10/26 no pe. ? filling defect in distal svc vs ivc. new bilateralpleural eff , stable cardiomeg , new fibrotic changes upper lobe , diffuseground glass opacities ( pulm edema vs pna )tte october 2007- ef 40% , rwmasr heart cath october 2007- wedge 12daily events:11/5 neg lenis , pulm consult ( fellow dellwo ) , had echo , getting sputum9/17 some neck swelling , maybe from mucomyst , dced mucomyst , now stable ,checking sputum for pcp2/12 improved neck swelling , nl ambulatory sats 95% on ra , and nl hrs in80s1/24 bronch showed active rml bleeding , bronchial washings performed ,fluid sent for microdischarge physical exam: afebrile , hr 80s-100s , bp 120s-130s/60s-80s ,94-95% ra. ambulatory o2 sat 87% ra.comfortable nad. lungs decreased breath sounds at bases. heart rrr , nomurmurs/rubs/gallops. jvp flat. abd soft. ext lle trace edema , rle edema.warm and well perfused.impression: 58yo m s/p cardiac transplant c/b allograft vasculopathy ,recent admission in 10/6 for pulmonary hemorrhage/pna admitted withincreased sob and hemoptysis. likely chf exacerbation +/- ild +/- pna( cap , atypicals , tb , pcp , fungal ). patient's shortness of breath respondedto diuresis , and his symptoms improved. however bronchoscopy revealedrml fresh blood , and ct chest is concerning for rml mass. will needfollow up with pulmonary which is already arranged.1. ) cv: no evidence of ischemia. patient continued outpatient asa ,bblocker , statin , plavix. h/o cardiac transplant. cyclosporine level on10/27 was 152. his cyclosporine was increased during admission to 100mg pobid. his sirolimus was discontinued.pump- he was intially volume overloaded on exam. bnp on admission was 674.he was diuresed with lasix 40mg po bid , and will be discharged on lasix40mg po daily. also given potassium 10meq a day , will need lytesfollowed. his hctz was discontinued. weight on day of discharge was62.2kg. bp control with home regimen of dilt , lopressor , cadura.2. ) pulm: pulmonary was consulted. ct was negative for pe. he had abronchoscopy which was described above ( fresh blood oozing from rml ). balwas sent for multiple studies. pcp was negative , influenza negative , adenonegative , viral studies , cultures , and cytology are pending at this time.galact ag was negative. gbm antibody was negative. anca is pending.bronchoscopy and chest ct were concerning for rml mass. he will follow upwith a pet ct and pulmonary appointment on 9/2/07. allergy was consultedre whether his symptoms could be an allergic pneumonitis ( given history ofasa allergy , an previous desensitization , and they felt it was unlikely.rheumatology was consulted re possible vasculitis given new proteinuria -thought unlikely although final consult recommendations were pending attime of discharge. he will be discharged on oxygen given desat to 87% onra with ambulation. he will be treated empirically with levofloxacin x 14day course to finish on 6/2/07 in case mass seen in rml is infectious.13. ) heme: lenis negative. has iron defiency anemia which will need to becontinued to follow.4. ) endo: niddm , diet controlled.6. ) renal: proteinuria , no explanation , will need further follow up.baseline renal dysfunction.full codeadditional comments: you were admitted to osweneer and hospital with shortness ofbreath. you were diuresed with furosemide ( lasix ) and your shortness ofbreath has improved. you have continued to need oxygen when you walk orexert yourself , and you will be discharged with oxygen which you shoulduse whenever you walk or exert yourself.you had a bronchoscopy during this hospital admission which revealed someblood in your right middle lung. you will need follow up with apulmologist regarding this finding. it is very important that you keepyour appointment for a follow up pet ct scan on 10/27 , and the appointmentthe same day with the pulmonologist. you also have an appointment withthe heart transplant service here at otmc on 3/15 , and it is importantthat you keep that appointment as well. please call your primary caredoctor and arrange to see him in the next week to follow up thishospitalization.there were several changes to your medication. these include:1 ) stop your sirolimus ( rapamune )2 ) increase cyclosporine to 100mg twice a day ( you had been taking 50mgtwice a day )3 ) stop your hydrochlorothiazide4 ) start furosemide ( lasix ) , a diuretic , 40mg once a day5 ) start levofloxacin , an antibiotic , and take one pill every other day tocomplete a fourteen day course , last day 6/2/076 ) start potassium chloride 10meq a day7 ) continue your other medicationsyou will have visiting nurses come to the house to assist you with youroxygen , medication checks and teaching , and a home safety evaluation.they should also check your electrolytes twice a week , and specificallymonitor your creatinine , potassium , and magnesium with reports to yourpcp who can adjust your medications.please seek medical attention if you again develop any shortness ofbreath , coughing up blood , chest pain , lightheadedness or fainting , orany other concerning symptoms.discharge condition: stableto do/plan:1 ) follow cyclosporine levels , sirolimus was discontinued during thishospital admission.2 ) follow up rheumatoid factor levels , hepatitis serologies , anca , ch50 ,iron deficiency anemia , proteinuria , bal viral studies , bal cultures3 ) follow up bal cytology4 ) follow up the lung mass seen on ct scan and blood oozing onbronchoscopy from rml. patient has a pet ct scheduled for 10/27 , andfollow up in pulmonary clinic 10/275 ) complete empiric levofloxacin course 14 days , last day 6/2/07labs onday of discharge k 3.5 ( given potassium ) , cr 1.9 , mg 1.9. hct27.5.no dictated summaryentered by: bramley , huey j. , m.d. ( sc914 ) 8/29/07 @ 02 end of discharge orders